Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Functional decline in Parkinson disease.

Jankovic J, Kapadia AS.

Arch Neurol. 2001 Oct;58(10):1611-5.

PMID:
11594919
2.

Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.

Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, Kaito M, Higashi K, Taki S, Kakeshita K, Fujino S, Miaki M.

J Neurol Sci. 2004 May 15;220(1-2):105-11.

PMID:
15140615
3.

Progression of motor impairment and disability in Parkinson disease: a population-based study.

Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP.

Neurology. 2005 Nov 8;65(9):1436-41.

PMID:
16275832
4.

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.

Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, et al.

Neurology. 1990 Oct;40(10):1529-34.

PMID:
2215943
5.

Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.

Tison F, Yekhlef F, Chrysostome V, Balestre E, Quinn NP, Poewe W, Wenning GK.

Mov Disord. 2002 Jul;17(4):701-9.

PMID:
12210859
6.

Parkinsonianlike signs and risk of incident Alzheimer disease in older persons.

Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA.

Arch Neurol. 2003 Apr;60(4):539-44.

PMID:
12707067
7.

Progression of parkinsonian signs in Parkinson disease.

Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K.

Arch Neurol. 1999 Mar;56(3):334-7.

PMID:
10190824
8.

Progression of gait disorder and rigidity and risk of death in older persons.

Wilson RS, Schneider JA, Beckett LA, Evans DA, Bennett DA.

Neurology. 2002 Jun 25;58(12):1815-9.

PMID:
12084882
9.

The rate of cognitive decline in Parkinson disease.

Aarsland D, Andersen K, Larsen JP, Perry R, Wentzel-Larsen T, Lolk A, Kragh-Sørensen P.

Arch Neurol. 2004 Dec;61(12):1906-11.

PMID:
15596611
10.

Contribution of aging to the severity of different motor signs in Parkinson disease.

Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Marder K.

Arch Neurol. 2005 Mar;62(3):467-72.

PMID:
15767513
11.

[Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].

Jost WH, Klasser M, Reichmann H.

Fortschr Neurol Psychiatr. 2008 Oct;76(10):594-9. doi: 10.1055/s-2008-1038249. Epub 2008 Oct 2. German.

PMID:
18833504
13.

The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.

Song J, Fisher BE, Petzinger G, Wu A, Gordon J, Salem GJ.

Neurorehabil Neural Repair. 2009 Sep;23(7):657-61. doi: 10.1177/1545968309332878. Epub 2009 Mar 31.

PMID:
19336530
14.

Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.

Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM.

J Neurol Sci. 2003 Aug 15;212(1-2):47-53.

PMID:
12809998
15.

Postural instability in idiopathic Parkinson's disease: discriminating fallers from nonfallers based on standardized clinical measures.

Landers MR, Backlund A, Davenport J, Fortune J, Schuerman S, Altenburger P.

J Neurol Phys Ther. 2008 Jun;32(2):56-61. doi: 10.1097/NPT.0b013e3181761330.

PMID:
18645292
16.

Gait festination in Parkinson's disease.

Giladi N, Shabtai H, Rozenberg E, Shabtai E.

Parkinsonism Relat Disord. 2001 Apr;7(2):135-138.

PMID:
11248595
17.

Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.

Diederich NJ, Moore CG, Leurgans SE, Chmura TA, Goetz CG.

Arch Neurol. 2003 Apr;60(4):529-33.

PMID:
12707066
18.

A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease.

Jankovic J, Hunter C.

Parkinsonism Relat Disord. 2002 Mar;8(4):271-6.

PMID:
12039422
19.

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N.

Brain. 2005 Oct;128(Pt 10):2240-9. Epub 2005 Jun 23.

PMID:
15975946
20.

The evolution of disability in Parkinson disease.

Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, Weiner WJ.

Mov Disord. 2008 Apr 30;23(6):790-6. doi: 10.1002/mds.21879.

PMID:
18361474

Supplemental Content

Support Center